MoneyWorks4Me

Neuland Laboratories - Quaterly Results

06 Aug 2026 Evaluate
The total revenue surged to Rs. 6415.77 millions, up 119.15% for the June 2026 quarter as against Rs. 2927.53 millions during the year-ago period.Net Profit for the quarter ended June 2026 zoomed to 975.01% from Rs. 137.08 millions to Rs. 1473.62  millions.Operating Profit saw a handsome growth to 2310.69 millions from 421.49 millions in the quarter ended June 2026.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 6415.77 2927.53 119.15 6415.77 2927.53 119.15 20229.85 14768.37 36.98
Other Income 84.92 78.56 8.10 84.92 78.56 8.10 301.64 205.09 47.08
PBIDT 2310.69 421.49 448.22 2310.69 421.49 448.22 6034.09 3428.08 76.02
Interest 69.72 45.83 52.13 69.72 45.83 52.13 239.45 82.96 188.63
PBDT 2240.97 375.66 496.54 2240.97 375.66 496.54 5794.64 4109.16 41.02
Depreciation 265.61 201.87 31.57 265.61 201.87 31.57 917.30 655.42 39.96
PBT 1975.36 173.79 1036.64 1975.36 173.79 1036.64 4877.34 3453.74 41.22
TAX 501.74 36.71 1266.77 501.74 36.71 1266.77 1246.29 859.48 45.01
Deferred Tax -7.06 -6.96 1.44 -7.06 -6.96 1.44 -42.55 122.95 -134.61
PAT 1473.62 137.08 975.01 1473.62 137.08 975.01 3631.05 2594.26 39.96
Equity 129.00 129.00 0.00 129.00 129.00 0.00 129.00 129.00 0.00
PBIDTM(%) 36.02 14.40 150.15 36.02 14.40 150.15 29.83 23.21 28.50
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..